BlackRock’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $603M | Buy |
|
|||||
|
2025
Q2 | $555M | Sell |
|
|||||
|
2025
Q1 | $553M | Sell |
|
|||||
|
2024
Q4 | $781M | Sell |
|
|||||
|
2024
Q3 | $835M | Sell |
|
|||||
|
2024
Q2 | $1.05B | Sell |
|
|||||
|
2024
Q1 | $1.4B | Buy |
|
|||||
|
2023
Q4 | $1.22B | Buy |
|
|||||
|
2023
Q3 | $1B | Sell |
|
|||||
|
2023
Q2 | $1.09B | Buy |
|
|||||
|
2023
Q1 | $966M | Sell |
|
|||||
|
2022
Q4 | $1.08B | Sell |
|
|||||
|
2022
Q3 | $1.04B | Sell |
|
|||||
|
2022
Q2 | $1.14B | Buy |
|
|||||
|
2022
Q1 | $1.49B | Buy |
|
|||||
|
2021
Q4 | $1.91B | Sell |
|
|||||
|
2021
Q3 | $2.1B | Buy |
|
|||||
|
2021
Q2 | $1.83B | Sell |
|
|||||
|
2021
Q1 | $1.62B | Buy |
|
|||||
|
2020
Q4 | $1.34B | Buy |
|
|||||
|
2020
Q3 | $1.21B | Buy |
|
|||||
|
2020
Q2 | $931M | Buy |
|
|||||
|
2020
Q1 | $563M | Sell |
|
|||||
|
2019
Q4 | $686M | Sell |
|
|||||
|
2019
Q3 | $610M | Sell |
|
|||||
|
2019
Q2 | $661M | Buy |
|
|||||
|
2019
Q1 | $666M | Buy |
|
|||||
|
2018
Q4 | $513M | Buy |
|
|||||
|
2018
Q3 | $607M | Buy |
|
|||||
|
2018
Q2 | $499M | Buy |
|
|||||
|
2018
Q1 | $443M | Buy |
|
|||||
|
2017
Q4 | $442M | Buy |
|
|||||
|
2017
Q3 | $432M | Sell |
|
|||||
|
2017
Q2 | $407M | Buy |
|
|||||
|
2017
Q1 | $346M | Buy |
|
|||||
|
2016
Q4 | $2.31M | Buy |
|
|||||
|
2016
Q3 | $2.52M | Sell |
|
|||||
|
2016
Q2 | $3.76M | Buy |
|
|||||
|
2016
Q1 | $2.36M | Sell |
|
|||||
|
2015
Q4 | $8.26M | Sell |
|
|||||
|
2015
Q3 | $8.96M | Buy |
|
|||||
|
2015
Q2 | $9.9M | Sell |
|
|||||
|
2015
Q1 | $14.2M | Buy |
|
|||||
|
2014
Q4 | $9.87M | Sell |
|
|||||
|
2014
Q3 | $16.4M | Sell |
|
|||||
|
2014
Q2 | $15.6M | Sell |
|
|||||
|
2014
Q1 | $29.2M | Buy |
|
|||||
|
2013
Q4 | $319K | Buy |
|
|||||
|
2013
Q3 | $278K | Hold |
|
|||||
|
2013
Q2 | $247K | Buy |
|